13F Data
13F filer · CIK 1009258

DEERFIELD MANAGEMENT COMPANY, L.P.

New York, NY · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$9.6B
+$1.1B vs prior
Positions
82
New / sold out
13 / 13
Added / reduced
14 / 12
Turnover
10.9%
buys $980.2M · sells $1.1B
Top-10 weight
53.2%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewREVOLUTION MEDICINES INC+200,000,000–+$251.7M
AddedGENMAB A/S+4,403,000+178.8%+$121.0M
NewCELCUITY INC+100,000,000–+$113.8M
NewMINERALYS THERAPEUTICS INC+3,958,000–+$106.8M
NewBOSTON SCIENTIFIC CORP+1,315,000–+$56.1M
NewPARABILIS MEDICINES INC+1,880,704–+$51.5M
AddedIDEAYA BIOSCIENCES INC+1,184,495+77.4%+$44.1M
AddedBIOMARIN PHARMACEUTICAL INC+481,280+56.5%+$27.5M
NewAVALYN PHARMACEUTICALS INC+731,000–+$24.1M
NewODYSSEY THERAPEUTICS INC+1,046,139–+$19.6M
17 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outMIRUM PHARMACEUTICALS INC-70,000,000-100.0%$-209.4M
ReducedCOGENT BIOSCIENCES INC-4,037,799-44.6%$-156.3M
Sold outCATALYST PHARMACEUTICALS INC-3,943,600-100.0%$-97.6M
Sold outNEUROCRINE BIOSCIENCES INC-610,000-100.0%$-80.4M
Sold outDAY ONE BIOPHARMACEUTICALS I-3,723,131-100.0%$-79.8M
Sold outENHABIT INC-4,747,746-100.0%$-66.9M
ReducedCENTENE CORP DEL-1,016,091-17.2%$-65.2M
ReducedINSPIRE MED SYS INC-1,406,376-52.0%$-62.7M
ReducedINDIVIOR PHARMACEUTICALS INC-1,448,895-46.8%$-59.4M
ReducedNEOGENOMICS INC-59,649,000-82.1%$-55.8M
15 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $2.1BQ3 2013: $2.2BQ4 2013: $1.9BQ1 2014: $2.4BQ2 2014: $2.5BQ3 2014: $2.7BQ4 2014: $2.8BQ1 2015: $3.1BQ2 2015: $3.0BQ3 2015: $2.6BQ4 2015: $2.5BQ1 2016: $2.3BQ2 2016: $2.5BQ3 2016: $2.2BQ4 2016: $2.4BQ1 2017: $2.6BQ2 2017: $1.9BQ3 2017: $2.2BQ4 2017: $2.5BQ1 2018: $2.9BQ2 2018: $2.8BQ3 2018: $2.8BQ4 2018: $2.5BQ1 2019: $2.6BQ2 2019: $2.8BQ3 2019: $2.5BQ4 2019: $3.1BQ1 2020: $3.2BQ2 2020: $3.4BQ3 2020: $4.1BQ4 2020: $5.1BQ1 2021: $4.8BQ2 2021: $5.6BQ3 2021: $5.1BQ4 2021: $4.8BQ1 2022: $4.5BQ2 2022: $4.8BQ3 2022: $5.0BQ4 2022: $4.8BQ1 2023: $4.5BQ2 2023: $4.7BQ3 2023: $4.5BQ4 2023: $5.4BQ1 2024: $5.7BQ2 2024: $6.0BQ3 2024: $6.7BQ4 2024: $5.3BQ1 2025: $5.1BQ2 2025: $5.5BQ3 2025: $6.6BQ4 2025: $7.8BQ1 2026: $8.5BQ2 2026: $9.6B
Q2 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1NUVALENT INCCOM17,248,450$2.1B22.22%
2BROOKDALE SR LIVING INCNOTE 3.500%10/1306,885,000$585.7M6.11%
3REVOLUTION MEDICINES INCCOM2,392,000$448.0M4.67%
4PRAXIS PRECISION MEDICINES ICOM NEW963,351$322.5M3.36%
5VIATRIS INCCOM20,206,170$320.9M3.35%
6CENTENE CORP DELCOM4,901,000$314.6M3.28%
7REVOLUTION MEDICINES INCNOTE 0.500% 5/0200,000,000$251.7M2.63%
8UNITED THERAPEUTICS CORP DELCOM457,000$247.6M2.58%
9ARROWHEAD PHARMACEUTICALS INNOTE 1/1200,000,000$240.5M2.51%
10LEGEND BIOTECH CORPSPONSORED ADS8,137,638$235.0M2.45%
72 more rows. Subscribe for $29/month to see every row, download the data and use the API.